COMPREHENSIVE PHASE-II EVALUATION OF AZIRIDINYLBENZOQUINONE (AZQ, DIAZIQUONE) IN RECURRENT HUMAN PRIMARY BRAIN-TUMORS

被引：19

作者：

EAGAN, RT

DINAPOLI, RP

CASCINO, TL

SCHEITHAUER, B

ONEILL, BP

OFALLON, JR

机构：

[1] MAYO CLIN & MAYO FDN, DEPT NEUROONCOL, ROCHESTER, MN 55905 USA

[2] MAYO CLIN & MAYO FDN, DEPT SURG PATHOL, ROCHESTER, MN 55905 USA

来源：

JOURNAL OF NEURO-ONCOLOGY | 1987年 / 5卷 / 04期

关键词：

D O I：

10.1007/BF00148387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：309 / 314

页数：6

共 13 条

[1]

COX BR, 1982, J R STAT SOC B, V34, P187

[2]

Cox DR., 1990, BIOMETRICS, V46, P550, DOI DOI 10.2307/2531476

[3]

CURT GA, 1983, CANCER RES, V43, P6102

[4]

DECKER DA, 1985, J NEURO-ONCOL, V3, P19

[5] POTENTIAL CNS ANTI-TUMOR AGENTS .6. AZIRIDINYLBENZOQUINONES-III [J].

DRISCOLL, JS ;

DUDECK, L ;

CONGLETON, G ;

GERAN, RI .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) :185-188

[6]

EAGAN RT, 1983, AM J CLIN ONCOL-CANC, V6, P577

[7] EVALUATION OF PROGNOSTIC FACTORS IN CHEMOTHERAPY OF RECURRENT BRAIN-TUMORS [J].

EAGAN, RT ;

SCOTT, M .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (01) :38-44

[8] A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS [J].

FEUN, LG ;

YUNG, WKA ;

LEAVENS, ME ;

BURGESS, MA ;

OBBENS, EA ;

BEDIKIAN, AY ;

SAVARAJ, N ;

STEWART, DJ ;

BENJAMIN, RS ;

FIELDS, WS ;

BODEY, GP .

JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) :13-17

[9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[10]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

← 1 2 →